A PEN INJECTOR FOR SELF-ADMINISTRATION OF FOLLITROPIN ALPHA SOLUTION WITH A MINIMAL DOSE INCREMENT OF 5 IU
To date, self administrations of recombinant human follicle-stimulating hormone (rhFSH) are carried out using pen injectors with minimal dose increments of 8.33 IU or 12.5 IU (IU – international units of activity). To ensure the accuracy of dose titration and to minimize the dose adjustments during...
Saved in:
Main Authors: | A. B. Podkorytov, O. V. Zhilyaev, M. A. Polzikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2018-02-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/447 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An observational study «FOLLITROPIN» comparing the efficacy of follitropin alpha biosimilar: the real-world data
by: D. P. Kamilova, et al.
Published: (2021-03-01) -
THE NOVEL BIOSIMILAR OF FOLLITROPIN ALPHA TO BE MANUFACTURED IN RUSSIA STARTING FROM 2017
by: I. I. Vorobiev, et al.
Published: (2017-12-01) -
Major results of a phase III comparative multicenter study on the follitropin alfa biosimilar (Primapur®) and the original follitropin alfa (Gonal-f®)
by: Z. B. Barakhoeva, et al.
Published: (2018-11-01) -
Real clinical practice of infertility treatment in Russia: a collective opinion of 425 reproductologists
by: N. V. Bashmakova, et al.
Published: (2024-01-01) -
Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022
by: D. G. Shchurov, et al.
Published: (2023-04-01)